NKGen Biotech, Inc. Common Stock (NKGN)
US$ 0.269-0.44%
Price Chart
Key Statistics
Market Cap
$ 14.37M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
581.59K
52W High
$ 1.05
52W Low
$ 0.10
Dividend Yield
0.00%
Beta
1.25
Technicals
50-Day MA
0.2697
200-Day MA
0.3361
52 Week High
1.05
52 Week Low
0.098
About NKGN
NKGen Biotech, Inc., a clinical-stage biotechnology company, develops cell therapies for neurodegenerative and oncological diseases based on activated natural killer (NK) cells.
Employees
63
Headquarters
Santa Ana, CA
CEO
Dr. Paul Y. Song M.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg